Zeven (dalbavancin) / RaQualia, AbbVie  >>  Phase 3
Welcome,         Profile    Billing    Logout  

13 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zeven (dalbavancin) / RaQualia, AbbVie
NCT02127970 / 2014-000419-15: Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Completed
3b
698
US, Europe, RoW
Dalbavancin, DALVANCE®, Dalbavancin-matching Placebo
Durata Therapeutics Inc., an affiliate of Allergan plc
Abscess, Wound Infection, Surgical Site Infection, Cellulitis
03/15
03/15
NCT01339091 / 2010-024042-30: Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Completed
3
573
US, Canada, Europe, RoW
Dalbavancin, Vancomycin / Linezolid
Durata Therapeutics Inc., an affiliate of Allergan plc
Abscess, Wound Infection, Surgical Site Infection, Cellulitis
09/12
11/12
NCT01431339 / 2011-002130-40: Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Completed
3
739
US, Europe, RoW
IV Dalbavancin, Vancomycin/Linezolid
Durata Therapeutics Inc., an affiliate of Allergan plc
Abscess, Wound Infection, Surgical Site Infection, Cellulitis
11/12
12/12
NCT02269644 / 2014-002683-32: A P3 Comparator Trial in Community Acquired Bacterial Pneumonia

Withdrawn
3
0
US
Dalbavancin, Dalvance, Linezolid, Zyvox, Linezolid Placebo, Azithromycin
Durata Therapeutics Inc., an affiliate of Allergan plc
Community Acquired Pneumonia
11/16
12/16
AHOM, NCT02344511 / 2014-004130-25: Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis

Withdrawn
3
0
US
Dalbavancin, Dalvance, cefazolin, nafcillin, oxacillin or vancomycin
Durata Therapeutics International BV (an Affiliate of Actavis, Inc.)
Osteomyelitis
10/18
04/19
2021-004038-12: Non Applicable

Not yet recruiting
3
406
Europe
Dalbavancin, Powder for concentrate for solution for injection/infusion, Xydalba
CENTRE HOSPITALIER ANNECY GENEVOIS, French Ministery of Health (DGOS), ADVANZ Pharma
Staphylococcus aureus catheter bloodstream infection, Bloodstream infection caused by the bacterium Staphylococcus aureus in patients with a catheter and with a low risk for S. aureus associated complications, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
NCT02814916 / 2014-005281-30: Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Completed
3
199
Europe, US, RoW
Dalbavancin, Xydalba, Vancomycin, Oxacillin, Flucloxacillin, Cefadroxil, Clindamycin
AbbVie
Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections
01/24
01/24
EndoDalba, NCT07699211 / 2026-526149-91-00: Dalbavancin Therapy for Infective Endocarditis

Not yet recruiting
3
184
Europe
Dalbavancin administration, Standard of Care (Investigator Choice)
Stefan Hagel
Endocarditis Infective, Endocarditis, Bacterial
09/28
12/29
DALICATH, NCT05117398 / 2024-514952-34-00 / 2021-004038-12: Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus

Recruiting
3
406
Europe
GENTAMICIN , CEFAZOLIN , VANCOMYCIN , TEDIZOLID , PRISTINAMYCIN , SULFAMETHOXAZOLE AND TRIMETHOPRIM , CEFOTAXIME, CEFTAROLINE FOSAMIL , AMOXICILLIN , OFLOXACIN , CLINDAMYCIN , TIGECYCLINE , LINEZOLID , AMIKACIN , LYMECYCLINE , CEFTRIAXONE , TEICOPLANIN , DOXYCYCLINE , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR , Xydalba 500 mg powder for concentrate for solution for infusion, LEVOFLOXACIN , DELAFLOXACIN , CIPROFLOXACIN , CLOXACILLIN , OXACILLIN , DAPTOMYCIN , AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , RIFAMPICIN
Assistance Publique - Hôpitaux de Paris, Centre Hospitalier de Perigueux, Advanz Pharma, Nantes University Hospital, Centre National de Référence des staphylocoques
Catheter related bloodstream infections due to Staphylococcus aureus
09/25
09/26
SUDDEN-OUT, NCT04847921: Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition

Terminated
2/3
11
US
Dalbavancin, Dalvance
University of Colorado, Denver
Gram-Positive Bacterial Infections, Gram-Positive Bacteraemia, Substance Use Disorders, Intravenous Substance Abuse
10/23
10/23
APHP220763, 2024-514952-34-00`2021-004038-12: Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterrelated bloodstream infections due to Staphylococcus aureus [DALICATH]

Recruiting
2/3
406
Europe
OXACILLIN , TEICOPLANIN , DELAFLOXACIN , CIPROFLOXACIN , TIGECYCLINE , LYMECYCLINE , PRISTINAMYCIN , CLOXACILLIN , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR , CEFTRIAXONE , DOXYCYCLINE , AMIKACIN , CEFAZOLIN , AMOXICILLIN , LEVOFLOXACIN , SULFAMETHOXAZOLE AND TRIMETHOPRIM , DAPTOMYCIN , LINEZOLID , CLINDAMYCIN , OFLOXACIN , TEDIZOLID , Xydalba 500 mg powder for concentrate for solution for infusion, RIFAMPICIN , CEFTAROLINE FOSAMIL , VANCOMYCIN , AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , CEFOTAXIME, GENTAMICIN
Assistance Publique Hopitaux De Paris, DGOS - French Ministry of Health
Catheter related bloodstream infections due to Staphylococcus aureus
 
 
20-AOI-03, 2024-518183-12-00`2020-003169-20: Efficacy of dalbavancin in osteoarticular infections associated with hip, knee and shoulder prostheses PRO-DALBA

Active, not recruiting
2/3
43
Europe
RIFAMPICIN, Xydalba 500 mg powder for concentrate for solution for infusion
Centre Hospitalier Universitaire De Nice, CHU de Nice
prosthetic joint infections
 
 
ZKSJ0165, 2026-526149-91-00: Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci

Not yet recruiting
2/3
166
Europe
LEVOFLOXACIN, BENZYLPENICILLIN POTASSIUM, DOXYCYCLINE, DAPTOMYCIN, CIPROFLOXACIN, CEFOTAXIME, AMOXICILLIN, CEFTRIAXONE, MOXIFLOXACIN, CEFALEXIN, FOSFOMYCIN, AMPICILLIN, DALBAVANCIN, RIFAMPICIN, FLUCLOXACILLIN, CEFACLOR, SULFAMETHOXAZOLE, CEFAZOLIN, CEFTAROLINE FOSAMIL, TRIMETHOPRIM, IMIPENEM, SULBACTAM, LINEZOLID, VANCOMYCIN, PHENOXYMETHYLPENICILLIN, GENTAMICIN SULFATE, CILASTATIN, MEROPENEM, CLAVULANIC ACID, TEICOPLANIN
Friedrich-Schiller-Universitaet Jena
Infectious endocarditis caused by Gram-positive cocci (staphylococci, enterococci, streptococci)
 
 

Download Options